DCM
KERX

DAFNA Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

DAFNA Capital Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-34,800
Closed -$443K – 87
2015
Q1 		$443K Buy
+34,800
New +$447K 0.34% 49
2014
Q3 		– Sell
-92,400
Closed -$1.42M – 63
2014
Q2 		$1.42M Sell
92,400
-7,600
-8% -$108K 1.35% 20
2014
Q1 		$1.7M Buy
100,000
+56,000
+127% +$845K 1.46% 17
2013
Q4 		$570K Sell
44,000
-30,100
-41% -$359K 0.59% 36
2013
Q3 		$748K Sell
74,100
-2,900
-4% -$25.8K 0.82% 32
2013
Q2 		$575K Buy
+77,000
New +$602K 0.84% 33

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return